Health Evaluation Allostatic Load Multiple Sclerosis (HEAL-MS)

Go Back to All Clinical Trials

Health Evaluation Allostatic Load Multiple Sclerosis (HEAL-MS)

Brief description of study

The role of childhood adversity has yet to be examined in pediatric-onset MS, despite data demonstrating that childhood adversity has been linked to earlier age of onset in MS1, disease progression, and poorer health outcomes in medical disorders including other autoimmune diseases. Adversity that prompts the recurrent and/or chronic experience of an acute stressor disrupts system-wide processes known as allostatic mechanisms. The multiple biomarker allostatic load (AL), the process through which chronic or recurrent exposure to stress induces cascading changes in the body’s stress-regulating mechanisms, has been developed to measure this disruption. We believe childhood adversity would be associated with increased AL, which is critical to the timing of MS onset. The evidence gap addressed by this study is in identifying biomarkers through which personal and geographic adversity/stress during childhood lead to MS onset early in life (i.e. before age 18 years).

Clinical Study Identifier: s22-00027

Principal Investigator: Lauren B. Krupp.

Other Investigators: Carrie Lyn Sammarco, Tyler Ellis Smith, Ilya Kister, Leigh E. Charvet, Jonathan E Howard, Robert W Charlson, Jiyuan Hu, Kimberly Ann O'Neill.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies